Cargando…

ICS/formoterol in the management of asthma in the clinical practice of pulmonologists: an international survey on GINA strategy

BACKGROUND: The treatment with short-acting beta-2 agonists (SABA) alone is no longer recommended due to safety issues. Instead, the current Global Initiative for Asthma (GINA) Report recommends the use of the combination of inhaled corticosteroids (ICS) with the rapid/long-acting beta-2 agonist for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cruz, Álvaro A., Barile, Sara, Nudo, Elena, Brogelli, Laura, Guller, Patricia, Papi, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844897/ https://www.ncbi.nlm.nih.gov/pubmed/33514439 http://dx.doi.org/10.1186/s40733-021-00067-z

Ejemplares similares

A summary of the new GINA strategy: a roadmap to asthma control
por: Reddel, Helen K., et al.
Publicado: (2015)

Cost-utility of as-needed ICS-formoterol versus to maintenance ICS in mild to moderate persistent asthma
por: Buendía, Jefferson Antonio, et al.
Publicado: (2021)

Asthma control with ICS-formoterol reliever versus maintenance ICS and SABA reliever therapy: a post hoc analysis of two randomised controlled trials
por: Hatter, Lee, et al.
Publicado: (2022)

The GINA asthma strategy report: what’s new for primary care?
por: Reddel, Helen K, et al.
Publicado: (2015)

Beclomethasone/formoterol fixed combination for the management of asthma: patient considerations
por: Nicolini, Gabriele, et al.
Publicado: (2008)

Diagnosis and management of asthma – Statement on the 2015 GINA Guidelines
por: Horak, Fritz, et al.
Publicado: (2016)

ICS-formoterol reliever versus ICS and short-acting β(2)-agonist reliever in asthma: a systematic review and meta-analysis
por: Hatter, Lee, et al.
Publicado: (2021)

Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update
por: Levy, Mark L., et al.
Publicado: (2023)

Two cheers for GINA?
por: McGuire, Amy L, et al.
Publicado: (2009)

A randomized, double-blinded, double-dummy efficacy and safety study of budesonide–formoterol Spiromax® compared to budesonide–formoterol Turbuhaler® in adults and adolescents with persistent asthma
por: Virchow, J. Christian, et al.
Publicado: (2016)

Triple Therapy with Mometasone/Indacaterol/Glycopyrronium or Doubling the ICS/LABA Dose in GINA Step 4: IRIDIUM Analyses
por: van Zyl-Smit, Richard N., et al.
Publicado: (2023)

Implementation of GINA guidelines in asthma management by primary care physicians in Vietnam
por: Nguyen, Vinh Nhu, et al.
Publicado: (2017)

Prescribing trends in and perceptions of the treatment of asthma: a survey among pulmonologists in Brazil
por: Cançado, José Eduardo Delfini, et al.
Publicado: (2019)

Asthma in pregnancy: association of asthma control test (ACT) with clinical management by the global initiative for asthma (GINA)
por: Araujo, Georgia, et al.
Publicado: (2015)

The correlation between the bronchial hyperresponsiveness to methacholine and asthma like symptoms by GINA questionnaires for the diagnosis of asthma
por: Lim, So Yeon, et al.
Publicado: (2014)

Are the Global Initiative for Asthma (GINA) Guidelines Being Correctly Used to Diagnose Severe Asthma in the UAE?
por: Abuzakouk, Mohamed, et al.
Publicado: (2020)

Classification of asthma according to revised 2006 GINA: Evolution from severity to control
por: Koshak, Emad A.
Publicado: (2007)

It is time to change the way we manage mild asthma: an update in GINA 2019
por: Muneswarao, Jaya, et al.
Publicado: (2019)

New approach to intermittent and mild asthma therapy: evolution or revolution in the GINA guidelines?
por: Kuprys-Lipinska, Izabela, et al.
Publicado: (2020)

International survey among hepatologists and pulmonologists on the hepatic hydrothorax: plea for recommendations
por: Cadranel, Jean-François David, et al.
Publicado: (2023)

Improvement in symptoms and pulmonary function of asthmatic patients due to their treatment according to the Global Strategy for Asthma Management (GINA)
por: Boskabady, Mohammad H, et al.
Publicado: (2008)

What pulmonologists think about the asthma–COPD overlap syndrome
por: Miravitlles, Marc, et al.
Publicado: (2015)

Gina DeNicola: In vivo veritas
por: Morgado-Palacin, Lucia
Publicado: (2023)

Stratification of eosinophilic asthma patients treated with reslizumab and GINA Step 4 or 5 therapy
por: Brusselle, Guy, et al.
Publicado: (2017)

Fixed-dose combination fluticasone/formoterol for asthma treatment in a real-world setting: meta-analysis of exacerbation rates and asthma control
por: Papi, Alberto, et al.
Publicado: (2023)

Prevalence of Patients with Uncontrolled Asthma Despite NVL/GINA Step 4/5 Treatment in Germany
por: Bergmann, Karl-Christian, et al.
Publicado: (2022)

Long-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma Exacerbations
por: Papi, Alberto, et al.
Publicado: (2016)

Disparate impacts and GINA: Congress's unfinished business
por: Wagner, Jennifer K
Publicado: (2019)

Dose-response relationship of ICS/fast-onset LABA as reliever therapy in asthma
por: Beasley, Richard, et al.
Publicado: (2019)

Attitudes of Croatian pulmonologists concerning obstacles to earlier, more appropriate use of biologics in severe asthma: Survey results
por: Grle, Sanja Popović, et al.
Publicado: (2021)

Budesonide/formoterol and formoterol provide similar rapid relief in patients with acute asthma showing refractoriness to salbutamol
por: Bateman, ED, et al.
Publicado: (2006)

Small Airways: The “Silent Zone” of 2021 GINA Report?
por: Cottini, Marcello, et al.
Publicado: (2022)

Symptom versus exacerbation control: an evolution in GINA guidelines?
por: Latorre, Manuela, et al.
Publicado: (2023)

Efficacy and safety of the single-capsule combination of fluticasone/formoterol in patients with persistent asthma: a non-inferiority trial
por: Antilla, Marti, et al.
Publicado: (2014)

Tuberous sclerosis complex for the pulmonologist
por: Rebaine, Yasmine, et al.
Publicado: (2021)

Treatment Patterns of Monoclonal Antibodies in Patients With Severe Uncontrolled Asthma Treated by Pulmonologists in Spain
por: Casas-Maldonado, Francisco, et al.
Publicado: (2023)

Asthma patients' inability to use a pressurised metered-dose inhaler (pMDI) correctly correlates with poor asthma control as defined by the Global Initiative for Asthma (GINA) strategy: a retrospective analysis
por: Levy, Mark L, et al.
Publicado: (2013)

Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma
por: Morice, A H, et al.
Publicado: (2007)

GiNA, an Efficient and High-Throughput Software for Horticultural Phenotyping
por: Diaz-Garcia, Luis, et al.
Publicado: (2016)

The view of pulmonologists on palliative care for patients with COPD: a survey study
por: Duenk, RG, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_r3c3jq4kuk6jrj1suabs5546p0